Work

Table S6 from CRB-701: A Second-generation Nectin-4–Targeted Antibody–Drug Conjugate with Optimized Stability and Pharmacokinetics for the Treatment of Solid Tumors

Year: 2026
Type: other
Abstract: Table S6. Stability of CRB-701 (0.02, 0.2, or 2 μM) over time following incubation with human, cynomolgus monkey, or Sprague Dawley rat plasma, or PBST control
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W7213299570
Cites:
Cited by:
Related to: 10